Elucidating the precise pharmacological mechanism of motion (MOA) of naturally developing compounds is usually tough. Whilst Tarselli et al. (60) formulated the very first de novo artificial pathway to conolidine and showcased that this naturally happening compound successfully suppresses responses to both equally chemically induced and inflammatio